Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.475
-0.025 (-1.67%)
Oct 6, 2026, 12:49 PM EDT - Market open
Allogene Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $14 | Buy | Maintains | $14 | +849.15% | Sep 30, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 17, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 13, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Reiterates $8 | Buy | Reiterates | $8 | +442.37% | Aug 13, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $9 | Buy | Reiterates | $9 | +510.17% | Aug 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $10 | Buy | Maintains | $10 | +577.97% | Aug 13, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 13, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $7 | Buy | Reiterates | $7 | +374.58% | May 14, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.